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INTRODUCTION
The outer layers of the placental villus are comprised of syncytiotrophoblasts and cytotrophoblasts [1] . The underlying stroma containing placental mesenchymal cells (PMCs), i.e., fibroblastic cells, express extracellular matrix (ECM) proteins that provide structural support to the villus [2] [3] [4] . Using immunohistochemistry and immunofluorescence techniques, several families of proteins have been 1 These studies were supported in part through NIH grant HD 33909 (S.G.). M.J.L. is the recipient of a NICHD Reproductive Scientist Development Program (K12-HD 00849)/Wyeth Scholarship. detected in the stromal ECM of the human placenta, including collagens, fibronectins (FNs), and laminins [2] [3] [4] . Although there is a wealth of information concerning the role of ECM proteins and their integrin receptors in differentiation and invasion of cytotrophoblasts [5] [6] [7] , relatively little is known concerning the regulation of ECM protein expression in PMCs. A previous report from our laboratory indicated that glucocorticoids (GCs) enhanced ECM protein production in PMCs and fibroblasts isolated from human amnion, and these GC-mediated changes were also noted in the baboon [8] . In addition, a recent study demonstrated that hypoxia selectively upregulated the expression of FN and collagen IV in PMCs [4] . Of clinical relevance is the observation that overexpression of ECM proteins by PMCs and villous fibrosis are characteristics of pregnancies associated with intrauterine growth restriction (IUGR) [9, 10] . It was suggested that this aberrant pattern of villous ECM protein expression may reduce the transfer of oxygen and nutrients from mother to fetus [9, 10] .
Transforming growth factor-␤ (TGF␤) comprises a cytokine family of three closely related peptides (TGF␤1, ␤2, ␤3) that function through membrane receptors (types I and II) [11] . Although the human placenta expresses TGF␤, the cellular distribution of the three peptides and their potential function remains the subject of debate [12] [13] [14] . TGF␤ type I and II receptors were also observed to be expressed by human placenta [15] [16] [17] . Early studies showed that TGF␤ treatment stimulated the synthesis of ECM proteins, including FNs, collagens, and their cell-surface integrin receptors in several cell types [18] [19] [20] . Oncofetal FN (FFN) is a uniquely glycosylated form of FN that is expressed in fetal tissue, at uterine-placental and chorionic decidual interfaces, and in cancer cell lines [21, 22] . It is of note that TGF␤ enhanced the expression of FFN in cytotrophoblasts isolated from human term placentas [23, 24] . In light of the relative dearth of information concerning the regulation of ECM protein levels in PMCs, the purpose of the present study was to elucidate the interaction between TGF␤ and GC in the modulation of ECM protein expression in these cells. We have used FFN as a model ECM protein for our study based on previous reports by our group and others demonstrating its expression in PMCs [4, 25] . Our results indicate that GCs specifically augment the effects of TGF␤ on specific ECM proteins synthesized by PMCs. These results are important to our understanding of the regulation of the ECM in the human placenta and its potential impact on villous architecture in uncomplicated pregnancies and those associated with villous fibrosis.
MATERIALS AND METHODS Materials
Tissue culture media and dexamethasone (DEX) were obtained from Sigma (St. Louis, MO). Bovine sera were obtained from Gemini Bio-FIG. 1. Effect of DEX and TGF␤ treatments on oncofetal fibronectin (FFN) levels in placental mesenchymal cells (PMCs). PMCs were maintained for 48 or 96 h in serum-free medium without (designated C for control) and with 100 nM DEX (designated D) and 1 ng/ml TGF␤ (designated T). Levels of FFN in the culture medium were measured by ELISA and were normalized to cell protein. Results are presented as a mean Ϯ SEM obtained in four independent experiments. * P Ͻ 0.05 vs. all other groups by ANOVA.
Products (Calabasas, CA). Laboratory plasticware was obtained from Falcon, Becton-Dickinson Labware (Lincoln Park, NJ). ITSϩ, a mixture containing insulin, transferrin, and selenium, was purchased from Collaborative Research-Becton Dickinson (Bedford, MA). 32 P-dCTP was from New England Nuclear (Boston, MA). Plasmids containing cDNAs to fibronectin and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were from the American Type Culture Collection (Rockville, MD). Other reagents used in tissue culture, ELISA, and Northern blotting procedures were from previously described sources [25, 26] .
Cell Culture
Human placental tissue (n ϭ 6) was obtained from uncomplicated pregnancies with normally grown, singleton fetus delivered by Cesarean section at term. A focus of the current study was the examination of GC effects on ECM protein expression. Therefore, tissues were not taken from women in labor because labor is associated with a marked rise in levels of GC in maternal and fetal sera and amniotic fluid [27, 28] . In addition, placentas were also not obtained from pregnancies characterized by toxemia, IUGR, preeclampsia, diabetes, abruptio placentae, or other pathologies. The experimental protocols and informed consent from patients was approved by the Institutional Review Board Committee at New York University School of Medicine.
Placental mesenchymal cells (PMCs) were isolated based on our previous method [8, 25] , which is a modification of procedures originally described by Fant and Nanu [29] . Five to 10 g of villous tissue were washed with saline and digested for 45 min in a 1:1 mixture of phenol red-free Ham F12-Dulbecco Modified Eagle medium (basal medium) containing 0.1% collagenase and 0.01% DNase. Dispersed cells were filtered through a 160-m stainless-steel sieve and centrifuged (500 ϫ g, 5 min). Cells were then resuspended in basal medium supplemented with 10% charcoal-stripped calf serum and ITSϩ (i.e., SCS medium) and seeded in two T-75 culture flasks. ITS ϩ supplementation yields a final concentration of insulin of 6.25 g/ml; transferrin, 6.25 g/ml; selenious acid, 6.25 ng/ ml; bovine serum albumin, 1.25 mg/ml; and linoleic acid, 5.35 g/ml. For experiments, PMCs between passage 3 and 10 were plated in SCS medium at a density of 5 ϫ 10 4 cells/well in a 24-well dish for ELISA studies and 1 ϫ 10 6 cells per 25 cm 2 flask for Northern blot and real-time polymerase chain reaction (PCR) analysis. After 3 days, at approximately 75% confluency, the cells were washed twice with PBS and serum-free medium (SCS medium without serum) was added with and without the indicated concentration of DEX and TGF␤. We noted that cells remained firmly attached to the substratum for at least 96 h in serum-free medium with and without 100 nM DEX and 1 ng/ml TGF␤. In two independent experiments, cell viability as judged by trypan blue exclusion following trypsinization, was Ն90% for cells maintained for 48 or 96 h in serum-free medium with and without DEX and TGF␤. In addition, no effect of treatment on cell number was noted. After the specified time in culture, conditioned media were saved for ELISA, and protein and RNA were extracted from adherent cells.
Cytotrophoblasts (CTs) were isolated from approximately 45 g of human villous tissue at term following trypsin digestion and centrifugation on Percoll gradients. We have previously employed this procedure [24, 25, 30] , originally described by Kliman et al. [31] and modified by Douglas and King [32] , to obtain CTs with purities of Ն95%. Initially, tissue fragments were chopped, washed with saline, and digestions with DNase and trypsin were carried out [30] . The digestate was poured through cheesecloth and two wire-mesh sieves with 0.0038 and 0.0021 inch openings and were centrifuged (500 ϫ g, 5 min). Pellets were resuspended for centrifugation on a continuous Percoll gradient [30] . CTs, sedimenting as a ring of cells at a density of approximately 1.05 g/ml, were washed and then treated with immunomagnetic microspheres conjugated to mouse antihuman CD-45 MAb to remove immune cells [30] . CTs were then resuspended in SCS medium before plating. The yield was approximately 3 ϫ 10 8 CTs/45 g of villous tissue. For experiments, CTs were plated in SCS medium at a density of 5 ϫ 10 5 cells/well in a 24-well dish, and after 24 h, the cells were washed twice with PBS and serum-free medium was added with and without 100 nM DEX and 1 ng/ml TGF␤. After 48 h, FFN content in culture media was determined by ELISA and normalized to cell protein. Results and statistical analysis are presented as a mean Ϯ SEM from six culture wells obtained in a single experiment representing three identically conducted ones.
PMCs and CTs were maintained at 37ЊC in SCS medium in a humidified atmosphere of 5% CO 2 /95% air.
Dose Response Studies
PMCs were plated in 24-well dishes and were maintained for 48 h in serum-free medium with and without 0.01-100 nM DEX and 0.001-1 ng/ ml TGF␤. These concentration ranges were chosen based on the observations that DEX and TGF␤ altered ECM protein synthesis with EC 50 s of approximately 2 nM and 0.05 ng/ml, respectively [23, 24, 33] . RU486, a GC antagonist, was used to determine whether DEX effects on FFN levels were mediated through the GC receptor. This compound was a gift from Dr. Indrani Bagchi (University of Illinois, Urbana, IL) and was used at 0.01 or 1 m (i.e., at a 10-fold molar excess compared with DEX) [34] . Levels of FFN in culture media were determined by ELISA in triplicate wells for each experimental condition and are presented as a mean Ϯ SEM. Figure 2 depicts results obtained in a single experiment representative of three identically conducted independent ones. Results were analyzed by ANOVA covering all treatments.
Hypoxic Treatment
Hypoxic treatment of cells was carried out as described by Esterman et al. [35] . Cultures of PMCs were incubated in sealed Plexiglas chambers (Belleco Glass Co., Vineland, NJ) containing a gas oxygen analyzer (Hudson RCI, Temecula, CA) and a beaker of water to maintain humidity. Air in the chambers was purged with 5% CO 2 /95% N 2 for 10 min after the oxygen meter read 0-1% O 2 . The sealed chambers were then placed in a 37ЊC incubator for the indicated time. Under these conditions, a reading of 1-3% O 2 was maintained for at least 48 h [35] . Control (i.e., normoxic) cultures were maintained in a standard humidified incubator of 5% CO 2 / 95% air (approximately 20% O 2 ). For experiments, cells were maintained for 48 h under normoxia or hypoxia in serum-free medium with and without 100 nM DEX and 1 ng/ml TGF␤. Levels of FFN in culture media were determined by ELISA. Results are presented as a mean Ϯ SEM of triplicate wells for each condition from a single experiment representative of three identically conducted ones.
FFN ELISA
FFN content of culture media from PMCs was measured by an ELISA using FDC-6 monoclonal antibody according to information provided by the manufacturer (Adeza Biomedical, Sunnyvale, CA) as we have described [24, 25] . The concentration of FFN in culture media was determined in triplicate wells and was normalized to cell protein using the D C Protein Assay from Bio-Rad Laboratories (Hercules, CA).
Northern Blotting
Northern blotting was used to assess levels of FN mRNA and was carried out as previously reported [8, 25] . Approximately 20 g RNA were 
Real-time PCR
For each experiment, Tri Reagent (Sigma) was used to extract RNA from duplicate flasks maintained for 48 h without (control) or with both 100 nM DEX and 1 ng/ml TGF␤. Before use in real-time PCR, 2.5 g of total RNA were reverse transcribed in a 20-l reaction containing 50 ng of random hexamers, 0.5 mM of each dNTP, 20 mM Tris-HCl (pH 8.4), 50 mM KCl, 5 mM MgCl 2 , 10 mM dithiothreitol, 40 U RNase inhibitor, and 50 U SuperScript II reverse transcriptase (Invitrogen, Carlsbad, CA). Control reactions were set up lacking reverse transcriptase to assess the level of contaminating genomic DNA. All reactions were carried out at 25ЊC for 10 min, 42ЊC for 50 min, and 70ЊC for 15 min. The RNA template was removed from the cDNA:RNA hybrid by incubation with 2 U RNase H at 37ЊC for 20 min. Amplification was performed on an iCycler iQ real-time PCR detection system (Bio-Rad). Primers for amplification of cDNAs were designed using Beacon Designer software (Bio-Rad) from Genbank cDNA sequences, and the uniqueness of primers was established using BLAST search analysis. Real-time PCR information is summarized in Table 1 . Primers were purchased from Invitrogen. The following primers were used: GAPDH; FN; laminin; collagens I, III, and IV. Aliquots containing 25 ng of cDNA were amplified in a total volume of 25 l containing 12.5 l of a 2ϫ iQ SYBR Green Supermix and 0.5 M of each primer. All samples were run in triplicate. The reactions were heated at 95ЊC for 3 min to activate Taq polymerase followed by 40 cycles of 95ЊC for 10 sec, 56ЊC for 30 sec, and 72ЊC for 30 sec. Melting curves of the products were obtained after cycling by stepwise increase of temperature from 55 to 95ЊC. PCR products were electrophoresed on agarose gels to confirm the presence of a single product of the expected size. For the relative quantification of gene expression, the comparative threshold cycle (C T ) method was employed as described in User Bulletin #2 for ABI PRISM 7700 Sequence Detection System (Applied Biosystems, Foster City, CA). C T represents the PCR cycle at which an increase in reporter fluorescence above a background signal can first be detected (10 times the standard deviation of the baseline). First, GAPDH C T values were subtracted from the gene of interest C T values to derive a ⌬C T value. The relative expression of the gene of interest was then evaluated using the expression 2
Ϫ⌬⌬CT
, where the value for ⌬⌬C T was obtained by subtracting the ⌬C T of the calibrator (i.e., the lowest control value within each experiment) from each ⌬C T in that experiment. Cumulative results are presented as mean Ϯ SEM of the fold change relative to the calibrator in five independent experiments.
Statistics
Results are expressed as a mean Ϯ SEM. Data were analyzed by AN-OVA or Student t-test using SigmaStat software from Jandel Scientific (San Rafael, CA). P Ͻ 0.05 was considered significant.
RESULTS

Regulation of FFN Expression in PMCs by DEX and TGF␤
PMCs were incubated for 48 or 96 h in serum-free medium with and without 100 nM DEX and 1 ng/ml TGF␤. In four independent experiments, we observed that treatment of PMCs with DEX and TGF␤ alone did not significantly affect FFN content in culture media (Fig. 1) . However, the combination of DEX and TGF stimulated a fourfold increase (P Ͻ 0.05) in FFN levels. We observed that DEX and TGF␤ effects on FFN expression in PMCs were dose-dependent between 0.01 and 100 nM DEX and 0.001 and 1 ng/ml TGF␤ (Fig. 2) . We noted that FFN levels in cells treated with 100 nM DEX and 1 ng/ml TGF␤ were greater than all other treatment groups (P Ͻ 0.05, denoted FIG. 3 . Effect of DEX and TGF␤ treatments on FN mRNA levels in PMCs. PMCs were incubated for 48 h in medium without (C) and with 100 nM DEX (D) and 1 ng/ml TGF␤ (T). RNA was then prepared and Northern blotting was carried out. Levels of FN and GAPDH mRNAs were determined following hybridization to 32 P-labeled cDNAs. The arrows to the left of the blot denote the positions of FN and GAPDH mRNA. A representative experiment of five identical independent ones is shown .  FIG. 4 . Analysis of DEX and TGF␤ effects on ECM protein expression in PMCs by real-time PCR. Cells were maintained for 48 h in serum-free medium under two conditions: without (unfilled bars) or with 100 nM DEX and 1 ng/ml TGF␤ (filled bars). RNA was extracted from cell lysates; converted to cDNA; and levels of FN, laminin (LN), Col I, III, and IV expression were quantitated by real-time PCR analysis using primers and reaction conditions described in Table 1 . Results are expressed as fold change relative to the calibrator (the lowest control value in each experiment, see Materials and Methods) and are presented as a mean Ϯ SEM obtained in five independent experiments. * P Ͻ 0.05; ** P Ͻ 0.01; *** P Ͻ 0.001 by Student t-test. by a single asterisk). In addition, FFN expression in cells treated with 10 nM DEX and 1 ng/ml TGF␤ or 100 nM DEX and 0.1 ng/ml TGF␤ were significantly higher than control (P Ͻ 0.05, denoted by a double asterisk). It is of note that FFN levels in cells treated with DEX and TGF and the GC antagonist RU486 were not significantly different from controls, suggesting that enhancement of FFN expression in TGF␤-treated cells by DEX was mediated through the GC receptor.
Northern Blot Analysis
PMCs were maintained in serum-free medium with and without 100 nM DEX and 1 ng/ml TGF␤ for 48 h and Northern blotting was carried out (Fig. 3) . We observed that DEX increased FN mRNA 36% Ϯ 26%, but the increase was not significant. However, FN mRNA expression increased 259% Ϯ 46% (P Ͻ 0.01) by TGF␤ and 317% Ϯ 61% (P Ͻ 0.01) by DEX and TGF␤.
Analysis of DEX and TGF␤ Effects on ECM Protein Expression in PMCs by Real-time PCR
Real-time PCR analysis was used to determine whether combined treatment of PMCs with DEX and TGF␤ coordinately affected the levels of expression of several ECM protein genes. For experiments, expression of FN, collagen (Col) I, II, III, and IV were analyzed and normalized to GAPDH levels (methodologic information is shown in Table 1). We observed that the combined treatment promoted a statistically significant two-to fourfold enhancement of FN (P Ͻ 0.001), Col IV (P Ͻ 0.01) and Col I (P Ͻ 0.05) expression, whereas no effect on laminin or Col III levels was noted (Fig. 4) . This indicated that GC and TGF␤ treatment selectively enhanced the expression of specific ECM protein genes in PMCs.
Effect of Hypoxic Treatment on FFN Levels in PMCs
Because hypoxia has been demonstrated to enhance ECM protein levels in several cell types [36] [37] [38] , in the current study, we wished to determine whether hypoxic treatment altered levels of FFN in PMCs treated with and without DEX and TGF␤. As shown in Figure 5 , hypoxic treatment for 48 h significantly increased FFN levels in controls by 41% (P Ͻ 0.05), whereas no effect of hypoxia was noted in cells treated with DEX and TGF␤ alone or TGF␤ plus DEX. Under both normoxic and hypoxic conditions, the combined treatment with DEX and TGF␤ increased FFN expression to a level that was statistically different from the three other treatment groups (P Ͻ 0.01, denoted by double asterisk).
Regulation of FFN Expression in Cytotrophoblasts (CTs) by DEX and TGF␤
To test whether the pattern of FFN regulation in human placenta showed cell-type-specific differences, we examined the effects of DEX and TGF␤ treatment on FFN expression in CTs isolated from human term placentas. CTs were maintained for 48 h in serum-free medium with and without 100 nM DEX and 1 ng/ml TGF␤, and levels of FFN in the culture medium were determined by ELISA (Fig. 6) . We observed that TGF␤ treatment alone significantly increased FFN expression in CTs 182% compared with control (P Ͻ 0.01), a similar trend to that noted with PMCs. However, in sharp contrast with the results obtained with PMCs, we observed that DEX treatment significantly reduced levels of FFN in CTs maintained without and with TGF␤ by 34% (P Ͻ 0.01) and 41% (P Ͻ 0.01), respectively. These results suggest that GCs regulate FFN expression in placenta in a cell-type-specific manner.
DISCUSSION
Expression of several types of ECM proteins by fibroblast-like cells in the stromal core of the placental villus (designated PMCs in the current study) provide a biological support for cytotrophoblast and syncytiotrophoblast layers on the surface of the villous and fetal capillaries below [1] [2] [3] [4] . Based on the importance of these ECM proteins in maintaining placental architecture, we examined ECM protein regulation in PMCs derived from human term placentas by GC and TGF␤, compounds known individually to alter ECM protein synthesis in several cell types [18] [19] [20] [23] [24] [25] [26] . Using FFN as a model, by ELISA, we initially demonstrated that DEX and TGF␤ synergistically enhanced ECM protein expression in PMCs. DEX and TGF␤ treatments stimulated FFN synthesis at concentrations consistent with those previously observed by our group and others [23, 24, 33] .
Our results suggest that the combined treatment of PMCs with GC and TGF␤ most likely enhanced ECM protein expression by a transcriptional mechanism because effects on ECM mRNAs noted in Northern blot and real-time PCR analyses were consistent with changes in protein noted by ELISA. It is possible that GC enhanced TGF␤ action in PMCs by altering the expression of TGF␤ receptors; both types I and II have been localized to the human placenta [15] [16] [17] . Alternatively, GC treatment could affect downstream signaling of TGF␤ by phosphorylated Smads (Sma and MAD gene homologues in Caenorhabditis elegans and Drosophila melanogaster) that bind to TGF␤-responsive 5Ј-upstream sequences [11] . Song and colleagues have demonstrated a direct, albeit inhibitory, interaction between glucocorticoid receptor (GR) and Smad3/4 binding to TGF␤-responsive sequences in the plasminogen activator inhibitor-1 gene [39] . It remains to be determined whether GR and Smads interact to regulate ECM protein expression.
It is of note in the present study that in the absence of DEX, TGF␤ effects on FN mRNA expression detected by Northern blotting (approximately 260% increase vs. control) were greater than its effects on levels of FFN protein determined by ELISA (approximately 65% stimulation vs. control). These differences may suggest that not all FN molecules released by PMCs contain the oncofetal epitope. This idea is supported by a previous study in which immunofluorescence revealed more staining for FN compared with FFN in the ECM of cultured placental fibroblasts [4] . It is possible that, in addition to its stimulatory effects on FN transcription, TGF␤ may also inhibit protein glycosylation and/or stability, resulting in lower levels of immunodetectable FFN. Significantly, real-time PCR analysis revealed that DEX and TGF␤ treatment enhanced expression of FN, Col IV, and Col I to a lesser extent, whereas levels of laminin and Col III were unaffected by treatment. These results suggest that GC and TGF␤ effects on ECM protein synthesis in PMCs were specific. The effects of DEX and TGF␤ treatment on FN and Col IV levels are of particular interest in that these proteins were demonstrated by immunofluorescence to be expressed at high levels in the villous stroma of both first-trimester and term placentas [2] [3] [4] .
In the current study, we compared FFN levels in PMCs maintained for 48 h under normoxic (20% O 2 ) and hypoxic (1-3% O 2 ) conditions. We observed that hypoxic treatment moderately increased (approximately 40%) FFN levels in PMCs not treated with DEX and TGF␤. These results are consistent with an earlier report demonstrating an increase in FFN levels of approximately 50% and 100% in placental fibroblasts maintained for 5 days under oxygen tensions of 3.4% and 0.4%, respectively [4] . The smaller effect of hypoxic treatment observed in our study may reflect the shorter period of exposure to hypoxia. It is noteworthy that, in the present study, hypoxic treatment did not augment FFN levels in cells treated with TGF␤. This may indicate that hypoxia enhances FFN expression in PMCs through an autocrine mechanism involving induction of TGF␤. The observation that hypoxic treatment stimulated TGF␤ expression in several cell types [40] [41] [42] supports this hypothesis. Thus, it is likely that GC, TGF␤, and hypoxia are all important regulators of ECM protein synthesis in PMCs.
Enhancement of FFN levels in TGF-␤-treated PMCs by DEX is surprising in light of the antagonistic interaction of GC and TGF␤ previously observed in several cell types [24, 43, 44] and in cytotrophoblasts in the present study. The well-known detrimental effect of GCs on wound healing is suggested to be due to suppression of TGF␤-mediated matrix protein production at the site of a wound [45] . Our results also demonstrated cell-type-specific regulation of ECM protein synthesis in human placenta by GC and TGF␤. We specifically noted that GC enhanced TGF␤ action in PMCs but inhibited TGF␤ effects in CTs. This finding supports our previous study in which GC treatment enhanced and suppressed FFN levels in amnion fibroblasts and epithelial cells, respectively. This same pattern of response to GC was also noted in epithelial cells and fibroblasts isolated from baboon amnion [8] .
Our findings predict that pregnancies associated with excessive placental exposure to GC would result in overexpression of ECM proteins by PMCs. Placentas from pregnancies with intrauterine growth restriction (IUGR) showed excessive villous fibrosis and ECM production by PMCs [9, 10, 46] . IUGR pregnancies typically have elevated umbilical cord Dopplers or absent diastolic flow, which is indicative of increased placental vascular resistance [47, 48] .
REGULATION OF MATRIX PROTEINS IN HUMAN PLACENTA
The enhanced ECM protein production by PMCs that we have demonstrated in our study and the villous fibrosis seen on histological examination [10, 46] may contribute to the clinical observation of increased placental vascular resistance. These changes in the villous stroma have been suggested to reduce the flow of nutrients from mother to fetus in pregnancies with IUGR [9, 10, 46] .
The level of GC in fetal sera was found to be higher in pregnancies with IUGR compared with gestational-agematched controls [49, 50] . The source of elevated periplacental GC in these pregnancies has been attributed to reduced placental levels of 11-hydroxysteroid dehydrogenase-2 (the enzyme that irreversibly converts cortisol to the receptor inactive cortisone) [51, 52] . In addition, a direct correlation has been noted between the number of doses of antenatal GC given to women at risk for preterm delivery and the severity of villous fibrosis [53] . Based on the results of the current study, we suggest that aberrant placental ECM protein synthesis in pregnancies with IUGR may be in part due to GC-mediated enhancement of TGF␤ effects in PMCs. Our results suggest that GC and TGF␤ effects on ECM protein synthesis play a key role in modulating placental architecture.
